Beltràn, Miquel

Does HER-2 status predict only a decreased response to hormone therapy in advanced breast cancer, or does it also predict the extent of metastatic disease? [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Dec 2002 - 4605; author reply 4606 p. digital

Publication Type: Comment; Letter

0732-183X

10.1200/JCO.2002.99.191 doi


Antineoplastic Agents, Hormonal--therapeutic use
Biomarkers, Tumor--analysis
Breast Neoplasms--chemistry
Female
Humans
Predictive Value of Tests
Receptor, ErbB-2--analysis
Research Design
Retrospective Studies